BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26230235)

  • 21. Screening for Lung Cancer With Low-Dose Computed Tomography: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center.
    Smetana GW; Boiselle PM; Schwartzstein RM
    Ann Intern Med; 2015 Apr; 162(8):577-82. PubMed ID: 25894026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung cancer screening with low-dose computed tomography: an analysis of the MEDCAC decision.
    Parker MS; Groves RC; Fowler AA; Shepherd RW; Cassano AD; Cafaro PL; Chestnut GT
    J Thorac Imaging; 2015 Jan; 30(1):15-23. PubMed ID: 25286290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The United States Preventive Services Task Force recommendations for lung cancer screening.
    Blackmon SH; Feinglass SR
    Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.
    Duma N; Santana-Davila R; Molina JR
    Mayo Clin Proc; 2019 Aug; 94(8):1623-1640. PubMed ID: 31378236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.
    Vachani A; Caruso C
    Curr Opin Pulm Med; 2023 Jul; 29(4):232-238. PubMed ID: 37191171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Cancer Screening.
    Choi HK; Mazzone PJ
    Med Clin North Am; 2022 Nov; 106(6):1041-1053. PubMed ID: 36280331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental renal tumours on low-dose CT lung cancer screening exams.
    Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
    J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.
    Robbins HA; Callister M; Sasieni P; Quaife SL; Cheung LC; Brennan P; Katki HA; Berg CD; Baldwin D; Johansson M
    Lancet Respir Med; 2019 Aug; 7(8):655-656. PubMed ID: 31076382
    [No Abstract]   [Full Text] [Related]  

  • 31. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?
    Bradley SH; Shinkins B; Kennedy MP
    J R Soc Med; 2021 Apr; 114(4):164-170. PubMed ID: 33715495
    [No Abstract]   [Full Text] [Related]  

  • 33. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for lung cancer: moving into a new era.
    Detterbeck FC; Unger M
    Ann Intern Med; 2014 Mar; 160(5):363-4. PubMed ID: 24379025
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer screening: one step forward.
    Mandell BF
    Cleve Clin J Med; 2012 May; 79(5):306. PubMed ID: 22550070
    [No Abstract]   [Full Text] [Related]  

  • 37. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.
    O'Dowd EL; Baldwin DR
    Br J Radiol; 2018 Oct; 91(1090):20170460. PubMed ID: 28749712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung Cancer Screening Using Low-Dose Computed Tomography.
    Hirsch B
    Radiol Technol; 2022 Jan; 93(3):303CT-321CT. PubMed ID: 35017276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
    Kowada A
    BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.